Navigation Links
Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
Date:9/6/2007

CAMBRIDGE, Mass., Sept. 6 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that management will present a corporate overview at the upcoming Bear Stearns 20th Annual Healthcare Conference on Tuesday, September 11th at 2:00 p.m. (EDT) and at the Maxim Group 1st Annual Growth Conference on Thursday, September 20th at 3:30 p.m. (EDT), both of which are being held in New York.

The live and archived webcasts of the presentations can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com. Please log in approximately 5-10 minutes before the events to ensure a timely connection. The archived replays will be available on the Idenix website for two weeks following the conferences.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV). For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceuticals' Contacts:

Media: Teri Dahlman (617) 995-9905

Investors: Amy Sullivan (617) 995-9838


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)... Output of New Molecular Entities Drops to Histori... Competition from Generics Companies, LONDON, Jul...omson,Reuters today announced the availability of ...eutical R&D Factbook, an indispensable reference,a...harmaceutical R&D,corporate finance, business str...
(Date:7/23/2008)... WINSTON-SALEM, N.C. A study out of Wake Forest ...rgency room doctors are correctly identifying pati...ratory tests haven,t yet confirmed it. , The stu...nalyzed patients with heart attack symptoms who we...t participating U.S. centers. , The findings we...
(Date:7/23/2008)... NASDAQ: CRME, TSX: COM, VANCOUVER, July 23 /...DAQ: CRME/TSX: COM) today announced that it has en...nts, LLC, an investment fund managed by,CR Intrins...Advisors, LLC,to purchase Series A convertible pre... Proceeds of the financing will be used for genera...
(Date:7/23/2008)... HOUSTON, July 23 /PRNewswire-FirstCall/ -- The... property and casualty company, today announced it...urricane Dolly, which is,sweeping through southern...-bin/prnh/20051031/NEM023LOGO ), "We are deeply ...y,s,path," said Robin A. Nicks, president of The H...
Breaking Medicine News(10 mins):Health News:Thomson Reuters Publishes CMR International's 2008 Pharmaceutical R&D Factbook, Now Available for the First Time Online 2Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3Health News:The Hanover Ready to Serve Policyholders Impacted by Hurricane Dolly 2
... get children especially the eight to 12-year-olds...uccess. The MEND programme, as it is called, got//...programme is opportune, considering that 30% of ch... or obese. MEND - for Mind, Exercise, Nutrition, a...
...e US has sentenced a man to prison for concealing ...a plasma collection center at Hammond.// Michael ...g blood contaminated with the HIV in September las...he liquid component of blood, in which the blood c...
... has found a new case of the deadly H5N1 strain of... the Saudi border.// "We now have 46 infected foc...n Wafra," said health ministry spokesman Ahmed al-...t individual cases. We concentrate on focal points...
... a technique with which newer ultrasound machines ...ts mother's womb.// The first image most parents ...that requires a remarkable stretch of imagination ... Newer machines can produce 3D images of babies by...
Other Medicine News:Health News:MEND - Child Obesity Programme Records Success 2
(Date:7/23/2008)... BOSTON, July 23 /- FluoroPharma ...imaging agents for the Positron Emission Tomograph... for BFPET, its novel,Fluorine-18 labeled tracer f...arma,s second cardiovascular product to complete P...ing agent, designed to assess the blood flow in th...
(Date:7/23/2008)... Company Focused on IND-Enabling Work with Pro...ive Pathway of Complement System, CAMBRIDGE, Mass...c.,today announced it has initiated a corporate gr...Ph.D., as chief executive officer and the,establis...Celniker succeeds,Woodruff Emlen, M.D., a co-found...
(Date:7/22/2008)... Latest awards under Therapeutics Development ...llaborations to 23; next deadline January 20,2009... part of its mission to,speed delivery of transfor...se, The Michael J. Fox Foundation for Parkinson,s ... to six industry research teams. The awards,were g...
(Date:7/22/2008)... Two Regimens Including Lantus(R) and Apidra(R)...ients with Type 2 Diabetes, Whatever the Algorithm...ER, N.J., July 22 /- Results from the...of a Simple Algorithm to Carbohydrate,Counting for...were,published in the American Diabetes Associatio...
Breaking Medicine Technology:FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Front Line Caregiver Coalition Thanks Sens Conrad Coleman and Reps Pomeroy Capito and Berkley for Leading Bipartisan Hill Effort to Stop Bush Admi 21200 1Front Line Caregiver Coalition Thanks Sens Conrad Coleman and Reps Pomeroy Capito and Berkley for Leading Bipartisan Hill Effort to Stop Bush Admi 21200 2Cline Davis 26 Mann Launches Platform Advisors 28TM 29 a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pha 21197 1Cline Davis 26 Mann Launches Platform Advisors 28TM 29 a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pha 21197 2Niacins role in maintaining good cholesterol 3545 1Duke chemist has new way to tell right from left 21192 1Duke chemist has new way to tell right from left 21192 2
Full automatic, ready-to-use strip washer.
The Wellwash 4 Mk 2 combines high performance and flexibility with reliability, simplicity and ease of use.
...m delivers an unmatched combination of speed, accu...n for assessing and monitoring a patient's A1C lev...s only a simple fingerstick and delivers A1C resul...and time-tested having received full NGSP certific...
...for the determination of A1c is also designed to d...a fully automated analyzer including primary tube ...ate in safety and positive identification. The ana...ll known to be interference-free and to produce th...
Medicine Products: